Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate β‐catenin activity in colon cancer cells
- 30 December 2009
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 49 (4) , 337-352
Abstract
The activity of β‐catenin, commonly dysregulated in human colon cancers, is inhibited by the vitamin D receptor (VDR), and this mechanism is postulated to explain the putative anti‐cancer activity of vitamin D metabolites in the colon. We investigated the effect of a common FokI restriction site polymorphism (F/f) in the human VDR gene as well as the effect of anti‐tumorigenic 1,25‐dihydroxyvitamin D3 (1,25D) and pro‐tumorigenic lithocholic acid (LCA) VDR ligands on β‐catenin transcriptional activity. Furthermore, the influence of a major regulatory protein of β‐catenin, the APC tumor suppressor gene, on VDR‐dependent inhibition of β‐catenin activity was examined. We report herein that β‐catenin‐mediated transcription is most effectively suppressed by the VDR FokI variant F/M4 when 1,25D is limiting. Using Caco‐2 colorectal cancer (CRC) cells, it was observed that VDR ligands, 1,25D and LCA, both suppress β‐catenin transcriptional activity, though 1,25D exhibited significantly greater inhibition. Moreover, 1,25D, but not LCA, suppressed endogenous expression of the β‐catenin target gene DKK‐4 independent of VDR DNA‐binding activity. These results support β‐catenin sequestration away from endogenous gene targets by 1,25D–VDR. This activity is most efficiently mediated by the FokI gene variant F/M4, a VDR allele previously associated with protection against CRC. Interestingly, we found the inhibition of β‐catenin activity by 1,25D–VDR was significantly enhanced by wild‐type APC. These results reveal a previously unrecognized role for 1,25D–VDR in APC/β‐catenin cross talk. Collectively, these findings strengthen evidence favoring a direct effect on the Wnt‐signaling molecule β‐catenin as one anti‐cancer target of 1,25D–VDR action in the colorectum.Keywords
This publication has 59 references indexed in Scilit:
- Vitamin D Receptor Gene Polymorphisms and the Risk of Colorectal Cancer in a Chinese PopulationDigestive Diseases and Sciences, 2008
- Association of vitamin D receptor gene variants, adiposity and colon cancerCarcinogenesis, 2008
- Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer riskBreast Cancer Research, 2008
- Vitamin D Receptor Polymorphisms and Renal Cancer Risk in Central and Eastern EuropeJournal of Toxicology and Environmental Health, Part A, 2008
- Vitamin D receptor polymorphisms and risk of epithelial ovarian cancerCancer Letters, 2008
- IL6 genotypes and colon and rectal cancerCancer Causes & Control, 2007
- The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesisDevelopmental Biology, 2007
- Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States)Cancer Causes & Control, 2004
- The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt PathwayPLOS Biology, 2003
- Role of bile acids in colorectal carcinogenesisEuropean Journal of Cancer, 1995